Literature DB >> 2525089

N-acetylglucosaminyltransferase III, IV and V activities in Novikoff ascites tumour cells, mouse lymphoma cells and hen oviduct. Application of a sensitive and specific assay by use of high-performance liquid chromatography.

A H Koenderman1, P L Koppen, C A Koeleman, D H van den Eijnden.   

Abstract

A specific and fast method for the determination of N-acetylglucosaminyltransferase III, IV and V activity in one assay is described. The method is based on the separation by HPLC of the three transferase products formed from the common acceptor oligosaccharide substrate GlcNAc beta 1----2Man alpha 1----3(GlcNAc beta 1----2Man alpha 1---- 6)Man beta 1----4GlcNAc. Assays are not interfered with by substances that result from enzymatic or chemical breakdown of the donor substrate UDP-[14C]GlcNAc. Using this assay system N-acetylglucosaminyltransferase III, IV and V activities were estimated in Novikoff ascites tumour cells, mouse lymphoma BW 5147 cells and hen oviduct.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525089     DOI: 10.1111/j.1432-1033.1989.tb14772.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

Review 1.  Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases.

Authors:  N Taniguchi; Y Ihara
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

2.  Determination of UDP-N-acetylglucosamine: beta-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody.

Authors:  Eun-Young Song; Kyung-Sook Kim; Kyoung-A Kim; Yung-Dai Kim; Dur-Han Kwon; Si-Myung Byun; Hee-Jung Kim; Tae-Wook Chung; Yong-Kyung Choe; Tai-Wha Chung; Cheorl-Ho Kim
Journal:  Glycoconj J       Date:  2002-07       Impact factor: 2.916

3.  Genetic variants near the MGAT1 gene are associated with body weight, BMI and fatty acid metabolism among adults and children.

Authors:  J A Jacobsson; M Rask-Andersen; U Risérus; G Moschonis; A Koumpitski; G P Chrousos; L Lannfelt; C Marcus; U Gyllensten; H B Schiöth; R Fredriksson
Journal:  Int J Obes (Lond)       Date:  2011-02-08       Impact factor: 5.095

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.